×
Back to Agenda
FDA Enforcement Update: Advertising and Promotion
Session Chair(s)
Lucy Rose, MBA
President, Lucy Rose and Associates, United States
FDA enforcement actions and policy guidances need to be understood by every company because they reflect FDA's priorities and concerns in regulating advertising and promotion. In this forum, an FDA professional and a representative from industry will examine the latest agency enforcement actions and policies and what they mean.
Learning Objective : Describe the latest FDA enforcement actions and policy initiatives in the area of advertising and promotion; Explain what the enforcement actions reflect about FDA policies and priorities.
Speaker(s)
Thomas W. Abrams, MBA, RPH
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER, Former FDA, United States
CDER Perspective
Lisa Stockbridge, PHD
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER, FDA, United States
CBER Perspective
Have an account?